简体中文 | 繁體中文 | English

Advisory/Reminders News

2015-10-12 15:53 Merck and Pfizer Announce Investigational Immunotherapy Avelumab Receives FDA Fast Track Designation for Metastatic Merkel Cell Carcinoma
2015-10-12 15:07 Octapharma AG Invests €80 Million to Acquire an Exclusive Worldwide License to Certain IP of Glycotope’s Recombinant Technology and to Become a Minority Shareholder of Glycotope GmbH Berlin
2015-10-12 14:53 ServiceSource Announces Plans to Open Service Delivery Center in Philippines
2015-10-12 13:49 Cell Therapy Catapult Launches Cell History File
2015-10-12 13:37 Mobile Industry Backs GSMA Embedded SIM Specification to Benefit from US$1.1 Trillion Internet of Things Opportunity
2015-10-12 11:57 Goldman Sachs, JPMorgan Chase, Morgan Stanley Join with SmartStream to Create New Reference Data Utility
2015-10-12 11:40 ACE Appoints New Marine Risk Manager
2015-10-12 11:33 Limelight Networks’ Content Delivery Network (CDN) Powers Chili S.p.A’s Over-the-Top Video (OTT) On-Demand Service
2015-10-12 11:13 O3b Networks the Fastest Growing Satellite Operator in History
2015-10-12 10:23 Toshiba's Image Sensor for Iris Recognition Brings New Level of Security to Mobile Devices
2015-10-12 10:00 Feld Entertainment and Primary Children’s Hospital Announce New Cancer Research Funding Effort
2015-10-12 09:44 Iao Kun Group Holding Company Limited Announces Rolling Chip Turnover of US$0.40 Billion for September 2015
2015-10-12 09:32 Celgene Announces New Data for OTEZLA® (Apremilast) Will Be Presented at European Academy of Dermatology and Venereology Congress
2015-10-10 15:44 Momentive Settles IP Legal Action against Qingdao Siltech
2015-10-09 18:35 NTE Energy Closes Financing for 475 MW PJM Project in Ohio
2015-10-09 18:23 Mobifone Chooses Synchronoss for Personal Cloud and Activation Services in Vietnam
2015-10-09 18:14 Huawei and Google Unveil the Ultimate Premium Smartphone: Meet the Nexus 6P
2015-10-09 18:08 Leading U.S. Corporate Lawyer Jon Gray Joins Davis Polk in Tokyo
2015-10-09 17:59 Arcadia Biosciences Receives Final Regulatory Approval for Stress Tolerant Soybeans in Argentina Through Verdeca Joint Venture
2015-10-09 17:43 Replicor Announces Initiation of Recruitment for Its Phase IIb Clinical Trial with REP 2139-Mg or REP 2165-Mg in Combination with Viread® and Pegasys® or Zadaxin® in Patients with HBeAg Negative Chronic Hepatitis B Infection

Business Wire Weibo

Press Releases

Latest Releases